Goodwill and Other Intangible Assets

9 Months Ended

Jan. 27, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in the carrying amount of goodwill for the nine months ended January 27, 2013 and fiscal year ended April 29, 2012, by reportable segment, are as follows:



	North American Consumer Products			Europe			Asia/Pacific			U.S. Foodservice			Rest of World			Total
	(In thousands)
Balance at April 27, 2011	$	1,111,737		$	1,221,240		$	392,080		$	257,674		$	315,710		$	3,298,441
Purchase accounting adjustments	—			(600		)	—			—			1,380			780
Disposals	—			(1,532		)	—			—			—			(1,532		)
Translation adjustments	(4,662		)	(73,820		)	3,119			—			(36,799		)	(112,162		)
Balance at April 29, 2012	1,107,075			1,145,288			395,199			257,674			280,291			3,185,527
Disposals	—			(527		)	—			(899		)	—			(1,426		)
Impairment loss	—			—			(36,000		)	—			—			(36,000		)
Goodwill allocated to discontinued operations	—			—			(4,526		)	—			—			(4,526		)
Translation adjustments	(3,642		)	(9,591		)	3,050			—			(28,865		)	(39,048		)
Balance at January 27, 2013	$	1,103,433		$	1,135,170		$	357,723		$	256,775		$	251,426		$	3,104,527

As a result of classifying the LongFong business as held-for-sale, the Company took a non-cash impairment charge of $36.0 million to goodwill based on the fair value of the anticipated sale. During the second quarter of Fiscal 2013, the Company changed its annual goodwill impairment testing date from the fourth quarter to the third quarter of each year. As such, the Company completed its annual impairment assessment of goodwill during the third quarter of Fiscal 2013. No additional impairments were identified during the Company's annual assessment of goodwill. Total goodwill accumulated impairment losses for the Company since Fiscal 2003 were $120.6 million consisting of $54.5 million for Europe, $38.7 million for Asia/Pacific and $27.4 million for Rest of World as of January 27, 2013.

Trademarks and other intangible assets at January 27, 2013 and April 29, 2012, subject to amortization expense, are as follows:



	January 27, 2013							April 29, 2012
	Gross		Accum Amort			Net		Gross		Accum Amort			Net
	(In thousands)
Trademarks	$	286,554	$	(90,953	)	$	195,601	$	282,937	$	(87,925	)	$	195,012
Licenses	208,186		(168,234		)	39,952		208,186		(163,945		)	44,241
Recipes/processes	87,189		(37,107		)	50,082		89,207		(35,811		)	53,396
Customer-related assets	211,482		(75,360		)	136,122		216,755		(69,244		)	147,511
Other	46,476		(26,388		)	20,088		48,643		(25,442		)	23,201
	$	839,887	$	(398,042	)	$	441,845	$	845,728	$	(382,367	)	$	463,361

Amortization expense for trademarks and other intangible assets was $7.7 million and $7.5 million for the third quarters ended January 27, 2013 and January 25, 2012, respectively and $23.1 million and $24.4 million for the nine months ended January 27, 2013 and January 25, 2012, respectively. Based upon the amortizable intangible assets recorded on the balance sheet as of January 27, 2013, annual amortization expense for each of the next five fiscal years is estimated to be approximately $31 million.

Intangible assets not subject to amortization at January 27, 2013 totaled $992.1 million and consisted of $855.3 million of trademarks, $117.1 million of recipes/processes, and $19.7 million of licenses. Intangible assets not subject to amortization at April 29, 2012 totaled $1.04 billion and consisted of $895.9 million of trademarks, $119.3 million of recipes/processes, and $20.1 million of licenses. The reduction in intangible assets, not subject to amortization expense, since April 29, 2012 is due primarily to translation adjustments and intangible assets allocated to discontinued operations.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details